Evidence map›Paper›PMID 24887202›Full record

ReviewBiochimica et biophysica acta2014

Interpreting human genetic variation with in vivo zebrafish assays.

Erica E Davis, Stephan Frangakis, Nicholas Katsanis

Open access · greenAbstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 75 citations in OpenAlex.

  1. Broadening horizons: Pathogenesis and therapeutics of renal ciliopathies.Journal of cell communication and signaling · 2026
    Review
  2. Article
  3. Modelling phenotypes, variants and pathomechanisms of syndromic diseases in different systems.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2024
    Article
  4. Review
  5. Article
  6. Garvicin KS, a Broad-Spectrum Bacteriocin Protects Zebrafish Larvae againstInternational journal of molecular sciences · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Functional testing of a humanDisease models & mechanisms · 2018
    Article
  15. BiallelicNeurology · 2018
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Erica E DavisCenter for Human Disease Modeling, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: erica.davis@duke.edu.
Stephan FrangakisCenter for Human Disease Modeling, Duke University Medical Center, Durham, NC 27710, USA.
Nicholas KatsanisCenter for Human Disease Modeling, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: katsanis@cellbio.duke.edu.
Duke University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
Molecular Genetics of BBSR01HD042601 · NICHD · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI DAVIS, ERICA ELLEN · 2003 to 2023
$8.2M
Genetic and Functional Studies of Human Ciliary SyndromesR01DK072301 · NIDDK · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI DAVIS, ERICA ELLEN · 2005 to 2022
$7.2M
Research Project 3P50DK096415 · NIDDK · DUKE UNIVERSITY · PI HAUSER, MICHAEL A · 2012 to 2016
$4.2M
The Role of Basa Bodies in Wnt SignalingR01DK075972 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI KATSANIS, NICHOLAS · 2007 to 2015
$3.1M
Modifiers of Retinal Phenotypes in CiliopathiesR01EY021872 · NEI · DUKE UNIVERSITY · PI DAVIS, ERICA ELLEN · 2011 to 2015
$1.9M
NEI NIH HHS R01 EY021872NICHD NIH HHS R01 HD042601NIDDK NIH HHS P50 DK096415NIDDK NIH HHS R01 DK072301NIDDK NIH HHS R01 DK075972NIGMS NIH HHS T32 GM007171
6 · The paper itself

Abstract

Rapid advances and cost erosion in exome and genome analysis of patients with both rare and common genetic disorders have accelerated gene discovery and illuminated fundamental biological mechanisms. The thrill of discovery has been accompanied, however, with the sobering appreciation that human genomes are burdened with a large number of rare and ultra rare variants, thereby posing a significant challenge in dissecting both the effect of such alleles on protein function and also the biological relevance of these events to patient pathology. In an effort to develop model systems that are able to generate surrogates of human pathologies, a powerful suite of tools have been developed in zebrafish, taking advantage of the relatively small (compared to invertebrate models) evolutionary distance of that genome to humans, the orthology of several organs and signaling processes, and the suitability of this organism for medium and high throughput phenotypic screening. Here we will review the use of this model organism in dissecting human genetic disorders; we will highlight how diverse strategies have informed disease causality and genetic architecture; and we will discuss relative strengths and limitations of these approaches in the context of medical genome sequencing. This article is part of a Special Issue entitled: From Genome to Function.

Indexed as

Allele pathogenicityDisease modelingGenomics

Identifiers

PMID24887202
PMCPMC4382103
OpenAlexW2139721236

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.